ArticleJournal of the Royal Society, Interface2018
A model-based analysis of tissue targeting efficacy of nanoparticles.
Article in Journal of the Royal Society, Interface, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Predictive Design and Analysis of Drug Transport by Multiscale Computational Models Under Uncertainty.Pharmaceutical research · 2023Review
- Quantitative Analysis of the Correlation between Cell Size and Cellular Uptake of Particles.Biophysical journal · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tissue targeting is a critical challenge for systemic delivery of drug nanocarriers. To overcome this challenge, major research efforts have been undertaken to design ligand-conjugated nanoparticles. However, limited work has been done to quantitatively assess the effectiveness of such approach. In this work, using a mechanistic spatio-temporal model, I investigate the effectiveness of ligand-directed tissue targeting. By applying an approach from the colloidal filtration theory, I develop a Brownian dynamics model of nanoparticle-cell interaction. The model incorporates a single cell and its surrounding flow field. It considers both specific (receptor-mediated) and non-specific (bare cell surface-mediated) recognition of nanoparticles subject to convective and diffusive motion. Using the model, I investigate how the specific and non-specific interactions compare in determining the overall targeting efficacy. My analysis provides some interesting findings that contradict the general notion that effective targeting is possible based upon the differential receptor expression in cancer and non-cancer cells. I show that such strategy may yield only a marginal gain in the targeting efficacy. Moreover, non-specific interaction may have an important influence on particle recognition by cells even at high receptor expression levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.